Name:Oliver Hao
Position:Co-CEO
Profile: Canada McGill University MBA/Canada CPA
Mr. Hao previously served as SVP of strategic development and GM at 111 Inc. (NASDAQ: 111) and participated in the company‘s IPO in 2018. Previously, he served as the co-CEO of Sinco Pharm (Hongkong: 6833), VP and GM of the pharmaceutical business in China for Cardinal Health.
Before that, Mr. Hao also worked as the finance director at Cardinal Health China and financial controller for Eli Lilly in China and Canada.
Mr. Hao has developed strong skills in such areas as strategic development, financial management, digital marketing and sales management.